BeOne Medicines
The Principal Scientist will lead discovery and translational efforts to advance breakthrough target discoveries in immunology, inflammation, and immuno‑oncology. This scientific leader will shape therapeutic strategy, design and execute rigorous studies, and mentor scientists while collaborating across functions to drive high‑impact pipeline opportunities.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1-10 employees
Founded
2010
BeOne Medicines, formerly BeiGene, is committed to advancing cancer care through a science‑led, purpose‑driven model that improves treatment access for patients worldwide.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BeOne Medicines.
35% above the average for this role
Faculty - Center for Innate Immunity and Inflammation, OSU Comprehensive Cancer Center (Open Rank/Track)
The Ohio State University
Associate Principal Scientist
Merck & Co., Inc.
Senior Principal Scientist, Discovery and Translational Immunology
MSD
Senior Scientist
Regeneron Pharmaceuticals
Business Development Manager - Immunology & Immuno-Oncology
QIMA
Director, Discovery Oncology, Reverse Translation
MSD